Predictors of outcome in patients with moderate mixed aortic valve disease.
Kush P PatelMichael McKennaGeorge D ThorntonSebastian VandermolenZaid Ali AbdulelahWael AwadAndreas BaumbachAnthony MathurThomas A TreibelGuy LloydMichael J MullenSanjeev BhattacharyyaPublished in: Heart (British Cardiac Society) (2023)
Patients with truly moderate MAVD have a high incidence of death and heart failure hospitalisation (43% at 3.5 (2.5-4.7) years). Within this group, a high-risk group characterised by disproportionately low aortic Vmax (≤2.8 m/s) and adverse remodelling (LVEF ≤50%) have the worst outcomes.
Keyphrases
- aortic valve
- heart failure
- transcatheter aortic valve replacement
- transcatheter aortic valve implantation
- aortic valve replacement
- aortic stenosis
- high intensity
- risk factors
- left ventricular
- emergency department
- coronary artery disease
- adverse drug
- acute heart failure
- pulmonary arterial hypertension
- glycemic control